Conferences

← vista completa

Published on June 1, 2010 | http://doi.org/10.5867/medwave.2010.06.4598

Diagnosis and initial therapy of community-acquired pneumonia (CAP)

Diagnóstico y terapia inicial de la neumonía adquirida en la comunidad (NAC)

Mauricio Ruiz

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Mauricio Ruiz

Sección de Enfermedades Respiratorias, Hospital Clínico Universidad de Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Ruiz M. Diagnosis and initial therapy of community-acquired pneumonia (CAP). Medwave 2010;10(06):e4598 doi: 10.5867/medwave.2010.06.4598

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/06/2010

Index

Metrics

Not available at the moment.

Notes

References

  1. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003;138:109-18. | PubMed
  2. Saldías F, Cabrera D, De Solminihac I, Hernández P, Gederlini A, Díaz A. Valor predictivo de la historia clínica y examen físico en el diagnóstico de neumonía del adulto adquirida en la comunidad. Rev Méd Chile 2007;135:143-52. | PubMed
  3. Ruiz M, Ewig S, Marcos AM. Etiology of community.acquired pneumonia: impact of age, comorbidity and severity. Am J Respir Crit Care Med 1999;160:397-05. | PubMed
  4. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250. | CrossRef | PubMed
  5. Woodhead M. Community-acquired pneumonia: severity of illness evaluation. Infect Dis Clin North Am 2004 Dec;18(4):791-807. | CrossRef | PubMed
  6. IDSA/ATS Guidelines CID 2007;44:S27-72. | Link
  7. Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339-44. | PubMed
  8. Moreno R, Riquelme R. Etiología de la neumonía adquirida en la comunidad en el adulto inmunocompetente. Rev Chil Enf Respir 2005;21:81-8.
  9. Fernandez R, Mauricio, Zagolin B, Mónica, Ruiz C, Mauricio et al. Neumonía adquirida en la comunidad que se hospitaliza: estudio etiológico. Rev Méd Chile mayo 2003, vol.131, no.5, p.498-504. | PubMed
  10. Díaz A, Barría P, Niederman M, Restrepo MI, Dreyse J, Fuentes G et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 2007;131:779-87. | CrossRef | PubMed
  11. Forest W. Arnold et al. A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia Am J Respir Crit Care Med. May 2007;175:1086-1093. | CrossRef | PubMed
  12. Menéndez R, Torres A, Zalacain R, Aspa J, Martin Villasclaras JJ, Borderias L, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59:960-965. | CrossRef | PubMed
  13. Martinez JA, Horcajada JP, Almela M y col. Addition of amacrolide to a B-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003;36:389-395. | CrossRef | PubMed
  14. Houck et al Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia. Arch Intern Med 2004;164:637-644. | CrossRef | PubMed